219 related articles for article (PubMed ID: 35779364)
1. Resolving adjuvant mode of action to enhance vaccine efficacy.
Turley JL; Lavelle EC
Curr Opin Immunol; 2022 Aug; 77():102229. PubMed ID: 35779364
[TBL] [Abstract][Full Text] [Related]
2. Rational design of polymer-based particulate vaccine adjuvants.
Huete-Carrasco J; Lynch RI; Ward RW; Lavelle EC
Eur J Immunol; 2024 Feb; 54(2):e2350512. PubMed ID: 37994660
[TBL] [Abstract][Full Text] [Related]
3. Using PAMPs and DAMPs as adjuvants in cancer vaccines.
Sun H; Hu W; Yan Y; Zhang Z; Chen Y; Yao X; Teng L; Wang X; Chai D; Zheng J; Wang G
Hum Vaccin Immunother; 2021 Dec; 17(12):5546-5557. PubMed ID: 34520322
[TBL] [Abstract][Full Text] [Related]
4. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood.
Laupèze B; Hervé C; Di Pasquale A; Tavares Da Silva F
Vaccine; 2019 Sep; 37(38):5670-5680. PubMed ID: 31420171
[TBL] [Abstract][Full Text] [Related]
6. Adjuvants for swine vaccines: Mechanisms of actions and adjuvant effects.
Charerntantanakul W
Vaccine; 2020 Oct; 38(43):6659-6681. PubMed ID: 32888738
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Adjuvants: Selection Criteria, Mechanism of Action Associated with Immune Responses and Future Directions.
Habib A; Anjum KM; Iqbal R; Jaffar G; Ashraf Z; Khalid MS; Taj MU; Zainab SW; Umair M; Zohaib M; Khalid T
Iran J Immunol; 2023 Mar; 20(1):1-15. PubMed ID: 36917475
[TBL] [Abstract][Full Text] [Related]
8. Principles in Immunology for the Design and Development of Vaccines.
Meyer CU; Zepp F
Methods Mol Biol; 2022; 2410():27-56. PubMed ID: 34914041
[TBL] [Abstract][Full Text] [Related]
9. Selection of adjuvants for vaccines targeting specific pathogens.
Sarkar I; Garg R; van Drunen Littel-van den Hurk S
Expert Rev Vaccines; 2019 May; 18(5):505-521. PubMed ID: 31009255
[TBL] [Abstract][Full Text] [Related]
10. Recent advances of vaccine adjuvants for infectious diseases.
Lee S; Nguyen MT
Immune Netw; 2015 Apr; 15(2):51-7. PubMed ID: 25922593
[TBL] [Abstract][Full Text] [Related]
11. Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates.
Li H; Monslow MA; Freed DC; Chang D; Li F; Gindy M; Wang D; Vora K; Espeseth AS; Petrovsky N; Fu TM
Vaccine; 2021 Dec; 39(51):7446-7456. PubMed ID: 34852943
[TBL] [Abstract][Full Text] [Related]
12. Commonly Used Adjuvant Human Vaccines: Advantages and Side Effects.
Villarreal R; Casale TB
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):2953-2957. PubMed ID: 32360184
[TBL] [Abstract][Full Text] [Related]
13. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.
Ong GH; Lian BSX; Kawasaki T; Kawai T
Front Cell Infect Microbiol; 2021; 11():745016. PubMed ID: 34692565
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques.
Phillips B; Van Rompay KKA; Rodriguez-Nieves J; Lorin C; Koutsoukos M; Tomai M; Fox CB; Eudailey J; Dennis M; Alam SM; Hudgens M; Fouda G; Pollara J; Moody A; Shen X; Ferrari G; Permar S; De Paris K
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089691
[TBL] [Abstract][Full Text] [Related]
15. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
16. Built-in adjuvants for use in vaccines.
Li Q; Li Z; Deng N; Ding F; Li Y; Cai H
Eur J Med Chem; 2022 Jan; 227():113917. PubMed ID: 34688011
[TBL] [Abstract][Full Text] [Related]
17. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
[TBL] [Abstract][Full Text] [Related]
18. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
19. [Composition and mode of action of adjuvants in licensed viral vaccines].
Wagner R; Hildt E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Apr; 62(4):462-471. PubMed ID: 30830257
[TBL] [Abstract][Full Text] [Related]
20. Vaccine adjuvants to engage the cross-presentation pathway.
Lee W; Suresh M
Front Immunol; 2022; 13():940047. PubMed ID: 35979365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
